Storia in 7 fonti

India's pharma sector braces for impact of proposed Trump tariffs on generic drugs

Analysts warn the levies could disrupt global drug supply chains, push up medicine prices for Americans and force Indian drugmakers to rethink their manufacturing strategies.

Raccontata da

biopharmadive.com

hindustantimes.com

thehindubusinessline.com

economictimes.indiatimes.com

timesofindia.indiatimes.com

newsbytesapp.com

theprint.in

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

channelnewsasia.comStai leggendo20 h fa

India's pharma sector braces for impact of proposed Trump tariffs on generic drugs

Analysts warn the levies could disrupt global drug supply chains, push up medicine prices for Americans and force Indian drugmakers to rethink their manufacturing strategies.

originale

Timeline cronologica

mercoledì 22 luglio 2026·biopharmadive.com
Trump threatens tariffs on imported generic drugs
While the possibility of levies on branded pharmaceuticals have had a limited impact on drugmaker revenues, tariffs of up to 200% on copycat medicines could — depending on the…
mercoledì 22 luglio 2026·hindustantimes.com
US to impose steep tariffs on generic medicine imports from Aug 2028
US to impose steep tariffs on generic medicine imports from Aug 2028

India's pharma sector braces for impact of proposed Trump tariffs on generic drugs

Confronto fonti

India's pharma sector braces for impact of proposed Trump tariffs on generic drugs

Timeline cronologica

Trump threatens tariffs on imported generic drugs

US to impose steep tariffs on generic medicine imports from Aug 2028

Trump's generic drugs tariff threatens Indian pharma's top market

US tariffs could raise drug prices, squeeze Indian generics

Trump's 200% generic drug tariff threat puts $9.7 billion Indian pharma exports at risk; industry says…

Stocks fall, pharma firms fret. Indian drug manufacturers sweat over Trump's 100% levy on generics

0, 100, 200: How Trump's latest generic medicines tariffs could affect India

Why these 8 stocks including Pharma majors will remain in focus on today following Trump’s tariff announcement

0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines

Sun Pharma, Cipla, other pharma stocks in focus as Trump unveils 100%, 200% tariffs on generic drugs from 2028

0%, 100%, then 200%: How Trump's new generic drug tariff plan could hit India

Trump threatens tariff on generic medicines: Should India be worried?

0, 100, 200: How Trump's latest generic medicines tariffs could affect India

Trump’s proposed generic drug tariffs ‘not practical’, says Indian pharma; US consumers will pay the price

0% now, 100% in 2 years, 200% by 2029—US plan for generic pharma tariffs & what it means for India

Pharma stocks bleed after Trump announces up to 200% tariff on generic drugs; Aurobindo, Sun Pharma & Cipla slide over 3%

Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% storm

Pharma stocks decline; Aurobindo Pharma down over 4%

Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?

Trump’s 100% generic drug duty threatens US low-cost supply

200% Trump tariff shock? India’s cheap pills may still beat US rivals

Indian pharma firms may yet survive Trump's 200% tariff bombshell

Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investors

Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive

US proposal to impose steep tariffs on generic medicines could significantly impact India: GTRI